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(ii)1. Current literature highlights
1.1. Tetramic and tetronic acids as b-secretase inhibitors
Alzheimer’s disease (AD) is a common age-related neuro-
degenerative disorder aﬀecting around 2% of the popula-
tion in industrialised countries. One in 10 individuals
over 65, and nearly half of those over 85 are likely to
develop the disease. There is currently no cure for AD,
but investigation by the scientiﬁc community has provided
insight into the biology of the disease and revealed several
options for treatment.
Brains of patients struck by AD are characterised by two
hallmark proteinaceous aggregates: amyloid plaques and
neuroﬁbrillary tangles. b-Amyloid plaques are speciﬁc for
AD, whereas tangles are also found in other disorders.
The ‘amyloid hypothesis’ assigns the central role to the
accumulation of b-amyloid peptide (Ab) in the brain. Ab
peptides derive from the abnormal cleavage of the b-amy-
loid precursor protein (b-APP). b-Secretase (BACE-1), is
a member of the pepsin family of aspartyl proteases and
plays a critical role in this amyloid cascade, as recent
reports have demonstrated a direct correlation between
increased BACE-1 activity and Ab production in AD brain
tissue.
It is possible to ﬁnd inhibitors of aspartic proteases
with pharmacological activity and therefore inhibition of
BACE-1 has been recognised as a tractable drug discovery
target. Most of the BACE-1 inhibitors published to date
share a peptidic character and mimic the scissile amide
bond of the natural substrate by a non-cleavable transition
state bioisostere. As a consequence they often display low
oral bioavailability and poor blood-brain barrier perme-
ation. Therefore, non-peptidic BACE-1 inhibitors are of
great interest for AD drug development. Recent eﬀorts
have identiﬁed tetronic, tetramic and N-substituted tet-doi:10.1016/j.comche.2006.10.001
E-mail: nterrett@ensemblediscovery.comramic acids that inhibit BACE-1 following synthesis on
Wang resin.1
In this work, compounds such as tetramic acids were syn-
thesised commencing with loading of Fmoc-protected
amino acids onto Wang resin. N-deprotection, amidation
and base-catalysed cleavage from resin with concomitant
cyclisation delivered compounds of general structure (i).
In this way a small library was synthesized as singletons
and compounds screened in a FRET assay for BACE-1
inhibition. One of the most potent compounds isolated
was (ii) which possessed an IC50 of 60 lM for BACE-1
inhibition. This work has identiﬁed a novel series of
tetramic acid BACE-1 inhibitors which possess low
48 N. K. Terrett / Combinatorial Chemistry - An Online Journal 8 (2006) 47–49molecular weight and are amenable to optimisation to
provide compounds with the potential for good oral
bioavailability.
1.2. Combinatorial synthesis of benzothiazoles and
evaluation of topoisomerase II inhibitory activity
2-(4-Aminophenyl)benzothiazoles display potent and selec-
tive antitumour activity against breast, ovarian, colon and
renal cell lines, but their mechanism of action has yet to be
elucidated. Of interest is the fact that compounds are active
only against certain human cancer cell lines such as breast
MCF-7, MDA 468, renal TK 10 and ovarian IGROV1.
The compound activities were considered to be related to
their metabolism, since the sensitive cell lines eﬃciently
retained and metabolised 2-(4-aminophenyl)benzothiazoles
to acetylated and 6-hydroxylated derivatives.
DNA topoisomerases (topo) are ubiquitous nuclear en-
zymes that control and modify the topological states of
DNA. They play important roles in processes such as rep-
lication, recombination and transcription by catalysing a
transient breakage of DNA in an ATP-dependent fashion,
allowing for the physical unwinding of DNA followed by
a resealing of the DNA of individual strands (topo I) or
double strands (topo II).
Topoisomerase activities are activated in cancer cell
growth, and thus are good targets for antineoplastic drugs.
A recent study has sought to investigate one possible mech-
anism for the cytotoxic activity of benzothiazoles through
the synthesis of 2-(substituted-phenyl)benzothiazoles and
subsequent evaluation of their cytotoxicity and ability to
inhibit topo II activities.2
The synthesis of a small library of 2-(substituted-
phenyl)benzothiazoles (general structure iii) was under-
taken on solid phase 4-methoxytrityl resin. The in vitro
cytotoxic activities of compounds were evaluated using
the human solid tumour cell lines: A549 (lung cancer),
Col2 (colon cancer), SNU-638 (stomach cancer), HT1080
(ﬁbrosarcoma cancer) and HL-60 (myeloid leukemia).
Upon screening of the library compounds it was determined
that these compounds exhibited less cytotoxicity than the
clinical agents ellipticine and doxorubicin. Compound
(iv), however, possessed selective cytotoxicity for myeloid
leukemic cancer cells (IC50 20 nM). Many compounds
proved to possess topo II inhibitory activity, with (iv) being
one of the most potent found with an IC50 of 72 lM.
This work has identiﬁed compound (iv) to possess similar
topo II inhibitory activity to the antitumour agent etopo-
side which was also a potential selective cytotoxicity agent
against myeloid leukemic cancer cells.S
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(iv)2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
The use of phenylsilane as a mild coupling reagent for amid-
ation reactions has been reported and applied to both solu-
tion- and solid-phase chemistry for a variety of amines and
carboxylic acids.3
The solid-phase synthesis of a new class of nucleobase-
modiﬁed peptide-mimetic oligomers has been described.
b-Peptoids and b-peptoid hybrids bearing thymine on the
side chain are prepared from N-Fmoc-N-[2-(thymin-1-yl)-
ethyl]-b-alanine.4
2.2. Solution-phase synthesis
Poly(ethylene glycol) (PEG 3400) has been used as a
soluble polymeric support for the synthesis of a series of
novel benzazepines. The key step for the preparation of these
heterocycles was a phosphine-free palladium-catalyzed
Heck reaction.5
A solution-phase synthesis for the preparation of substi-
tuted 2-(1,2,4-triazol-3-yl)benzimidazoles from triazole
aldehydes and ortho-phenylenediamines has been devel-
oped for the purpose of producing diverse lead generation
libraries.6
2.3. Scaﬀolds for combinatorial libraries
DNG nucleotides represent a positively charged DNA
analogue in which the negatively charged phosphodiester
linkages of DNA are replaced by positively charged
guanidinium linkages. The synthesis of 3 0-end, middle,
and 5 0-end monomers required for the synthesis of a
DNG sequence in which the natural guanine base is re-
placed by 7-deazaguanine (c7G), chosen because of their
unique glycoside bond stability and their ability to prevent
G-quartet formation, has been reported.7
An improved synthesis of 3-azido-4-hydroxy cyclopenta-
noic acid has been presented. This molecule is useful as a
synthetic scaﬀold for b-turn mimetics on solid phase, with
the selectivity of the turns being dependent on the diaste-
reomer employed. A high diastereoselectivity in the synthe-
sis of this molecule in solution has been reported, which
may then be attached to the solid phase for the synthesis
of peptidomimetic libraries.8
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
A solid phase with spermine or polyethyleneimines tethered
by o-nitrobenzyl linkages has been synthesised with poly-
ethylene oxide beads (ArgoGel-NH2). The photolysis of
test compounds with the o-nitrobenzyl linker was complete
through photoirradiation at 365 nm for 10–18 min. The
potential exists to employ a DNA-loaded solid phase for
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at extracellular or intracellular sites.9
2.6. Library applications
Combinatorial libraries of small organic compounds
capable of cleaving RNA have been synthesised. The
compounds contain benzene rings substituted with two
residues of the bis quaternary salt of diazabicyclo-
[2.2.2]octane (DABCO) bearing hydrophobic fragments
of diﬀerent length and structure, attached to DABCO at
the bridge position. To identify the most active artiﬁcial
ribonucleases, sublibraries and truncated libraries, contain-
ing compounds lacking one substituent were synthesised.10
A natural aromatic residue in the lock-and-key joint at the
subunit interface of the dimeric glutathione transferase P1-
1 has been replaced by an S-alkylcysteine residue to give a
functional enzyme. Introduction of Cys in the key position
inactivates the enzyme, but subsequent alkylation of this
residue enhances the catalytic eﬃciency up to 27,000-fold.
Combinatorial modiﬁcation of Cys by a mixture of
reagents facilitated identiﬁcation of an n-butyl group as
the most eﬃcient activator.11
A series of phenothiazine derivatives, which were used to
test the structure–activity relationship of binding to HIV-
1 TAR RNA, have been synthesised. Binding characteris-
tics were ascertained via NMR, principally by saturation
transfer diﬀerence spectra of the ligand and imino proton
resonance shifts of the RNA.12References
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